147 results
Page 6 of 8
6-K
EX-2.1
2ylkegi0
15 Jun 10
Current report (foreign)
12:00am
6-K
izvxp3ygvf5ks
18 May 10
Current report (foreign)
12:00am
6-K
3ogjt5 jm0
18 May 09
Current report (foreign)
12:00am
6-K
EX-99.6
lgtvwqd
8 Dec 08
Teva Draws on $1.75 Billion Bridge Financing In Connection with Pending Barr Acquisition
12:00am
F-4/A
t8bfmmcd1q
14 Oct 08
Registration of securities (foreign) (amended)
12:00am
F-4
jczh0q
16 Sep 08
Registration of securities (foreign)
12:00am
425
EX-2.1
uqt5aljra6y4g
18 Jul 08
Business combination disclosure
12:00am
6-K
EX-2
wvpq1x cy
18 Jul 08
Report of Foreign Private Issuer
12:00am
6-K
3c3wmfv1445l1cp
7 Jul 08
Teva Provides Update on Forte Trial
12:00am
6-K
n2iizwcihnk09mosng1
30 Jun 08
Teva & Anp Announce That ATL/TV1102, a Novel Drug for the Treatment of Relapsing Remitting Multiple Sclerosis (RRMS), Demonstrated Significant Reduction In Disease Activity
12:00am
6-K
44mvc wiro2
23 May 08
Current report (foreign)
12:00am
6-K
oukauokc ze8wefvaht
10 Apr 08
Copaxone? Significantly Reduced Annual Relapse Rates and Stabilized Disease Progression In Relapsing Remitting Multiple Sclerosis Patients Failing Interferon Treatment
12:00am
6-K
EX-2.1
570j3h
3 Apr 08
Current report (foreign)
12:00am
425
EX-10.1
8lvigs394nq5r1n0
1 Apr 08
Business combination disclosure
12:00am